Pierre Van Damme
Pierre Van Damme (MD, PhD, University of Antwerp) is professor at the University of Antwerp, in Vaccinology since 2000.
He is director of the Centre for the Evaluation of Vaccination (CEV), a WHO Collaborating Centre, and of Vaccinopolis, a state-of-the-art facility for ambulatory vaccine trials and human challenge studies, established in 2022.
Over more than 35 years, he has led or co-led over 550 vaccine trials and authored more than 600 peer-reviewed publications.
His research focuses on the epidemiology and prevention of vaccine-preventable diseases.
His team is currently part of the EU-European Vaccine Hub consortium and the CEPI-HERA MUSICC consortium for the assessment of future candidate vaccines and next generation mucosal COVID-19 vaccines. He has served as advisor to (inter)national health bodies.
He is member of the Belgian NITAG.
He is co-founder of the European Plotkin Institute for Vaccinology, aimed at accelerating vaccine evaluation for pandemic and endemic threats.